描述
CTS B-27 Supplement XenoFree Minus Vitamin A is based on the classic B-27 Supplement formulation and contains no animal-derived components at the primary component level. The absence of vitamin A (retinyl acetate) makes this formulation ideal for the cultivation of neural progenitor and stem cells, either as neurospheres in suspension or in adherent monolayer culture, without inducing differentiation. CTS B-27 Supplement XenoFree Minus Vitamin A reduces the burden in qualifying reagents when transitioning from the research bench to the clinic.
CTS quality Gibco CTS products are manufactured at a site that uses methods and controls that conform with cGMP for medical devices, 21 CFR Part 820. Our FDA-registered manufacturing sites are ISO 13485– and ISO 9001–certified.
Formulated xeno-free The preparation contains no animal-derived components at the primary component level.
Accompanied by documentation to support your regulatory filing Specific intended-use statements, full documentation traceability, and convenient access to our Drug Master File (DMF) are available.
For other applications, we provide alternative formulations of
CTS B-27 supplements and CTS Neurobasal media.
For established protocols using B-27 Supplement, access our
Gibco Neurobiology Protocol Handbook.
View publications using Gibco neurobiology products at our
Gibco CellCite.
新浪微博
腾讯微博
QQ空间
客服
